Task: Answer Verification
Input (English): Question: Is routine prophylactic granulocyte colony stimulating factor ( GCSF ) necessary with accelerated ( dose dense ) paclitaxel for early breast cancer?
Answer: Accelerated paclitaxel in breast cancer patients without prophylactic GCSF is safe, avoids side effects, reduces costs and is not associated with an increase risk of neutropenic sepsis or treatment delays.
Output (English): no